Angiotensin converting enzyme (ACE) inhibitor or angiotensin II receptor blocker (ARB) ameliorate proteinuria and induce regression beyond effects on systemic blood pressure in CKD [4,5,6]. This evidence concerns the gene ACE and chronic kidney disease.